|Articles|June 2, 2003
- Pharmaceutical Technology-06-02-2003
- Volume 27
- Issue 6
Formulation Development of a Nucleotide Phosphoramidate
Author(s)Manoj Maniar, PhD
A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.
Advertisement
Articles in this issue
over 22 years ago
June 2003over 22 years ago
From Genome Exploration to Drug Developmentover 22 years ago
Are you ready for Gen3over 22 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
4
De-risking Biologic Development: Engineering Flexibility from Early Development to Launch
5